Instagram Ern-EyeFacebook Ern-EyeTwitter Ern-EyeLinkedIn Ern-EyeYouTube Ern-EyeHow to use the speech recognition tool?
NCT02771379
PAROS
A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber’s Hereditary Optic Neuropathy (LHON).
Type: Observational
Status of the trial: Completed
Orphan Drug Recognition: NA
Inclusion
- Opening Date: 2016-09-01
- Closing Date: 2021-02-01
Criteria
Inclusion: Patient prescribed Raxone® for the treatment of LHON; Patient has completed an Informed Consent Form (ICF) indicating that he/ she (or a legally acceptable representative) has been informed of all pertinent aspects of the study and has agreed to participa
Exclusion: No explicit exclusion criteria exist to avoid selection bias and to allow for documentation of routine clinical practice.
Children: No
Adults: No
Funder Type: industry
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
Workgroups
Neuro-Ophthalmology Rare Diseases (WG2)
This ERN is supported by:
